CLEC4M and COVID-19: We show that amongst patients hospitalised with COVID‐19, 19.5% have IgM autoantibodies against CD209L, and 5.9% have antibodies against CD209, whereas 6% and 5%, respectively, is the frequency of the IgG isotypes.